| Income Statement | 2025-10-31 | 2025-07-31 | 2024-10-31 | |
|---|---|---|---|---|
| Revenue | 2,419 | 1,900 | - | |
| Cost of sales | 1,008 | 760 | - | |
| Gross margin | 1,411 | 1,140 | - | |
| Research and development | 727,026 | 997,206 | 1,198,965 | |
| Selling, general and administrative | 1,347,788 | 878,053 | 786,068 | |
| Total operating expenses | 2,074,814 | 1,875,259 | 1,985,033 | |
| Loss from operations | -2,073,403 | -1,874,119 | -1,985,033 | |
| Interest expense | 279,534 | 183,688 | 117,598 | |
| Other income | 2,168 | 2,813 | 19,713 | |
| Total other expense | -277,366 | -180,875 | -97,885 | |
| Net loss | -2,350,769 | -2,054,994 | -2,082,918 | |
| Earnings per share, basic, total | -0.85 | -1.58 | -2.27 | |
| Earnings per share, diluted, total | -0.85 | -1.58 | -2.27 | |
| Weighted average number of shares outstanding, basic, total | 2,780,496 | 1,303,532 | 917,445 | |
| Weighted average number of shares outstanding, diluted, total | 2,780,496 | 1,303,532 | 917,445 | |
HeartSciences Inc. (HSCS)
HeartSciences Inc. (HSCS)